Loss of Heterozygosity of the TP53 Tumor Suppressor Gene and Detection of Point Mutations by the Non-Isotopic RNAse Cleavage Assay in Prostate Cancer
- 1 January 1999
- journal article
- Published by Elsevier in Cancer Genetics and Cytogenetics
- Vol. 108 (1) , 42-47
- https://doi.org/10.1016/s0165-4608(98)00109-5
Abstract
No abstract availableKeywords
This publication has 15 references indexed in Scilit:
- Progress in prostate cancerNature Genetics, 1995
- p53 Status and the Efficacy of Cancer Therapy in VivoScience, 1994
- p53 in Prostate Cancer: Frequent Expressed Transition MutationsJNCI Journal of the National Cancer Institute, 1994
- P53 Oncogene Mutations in Human Prostate Cancer SpecimensJournal of Urology, 1994
- Cancer statistics, 1994CA: A Cancer Journal for Clinicians, 1994
- Prostate cancer. An overview of an increasing dilemmaCancer, 1993
- Wild-type p53 is a cell cycle checkpoint determinant following irradiation.Proceedings of the National Academy of Sciences, 1992
- Alterations of The P53 Gene Are Associated With The Progression Of A Human Prostate CarcinomaJournal of Urology, 1992
- The p53 tumour suppressor geneNature, 1991
- Mutations in the p53 gene occur in diverse human tumour typesNature, 1989